REG - Indivior PLC - Director Declaration

IndiviorAnnouncement

19/09/2018 15:40

RNS Number : 3081B
Indivior PLC
19 September 2018
 


Indivior PLC (the 'Company')
 
Indivior PLC confirms that Mr Howard Pien, Non-Executive Chairman, was appointed as an independent director of Idera Pharmaceuticals, Inc., a specialty pharmaceutical company listed on the NASDAQ Stock Market, with effect from September 18, 2018.
 
This announcement is made in accordance with Listing Rule 9.6.14.
 
Kathryn Hudson
Company Secretary
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNFKCDNQBKDPCD